<HTML>


<HEAD>








<TITLE>UNITED STATES </TITLE>


</HEAD>


<BODY>





<P ALIGN="CENTER"></P>


<B><FONT SIZE=5><P ALIGN="CENTER">UNITED STATES </P>


</B></FONT><FONT SIZE=2><P ALIGN="CENTER"></P>


</FONT><B><FONT SIZE=5><P ALIGN="CENTER">SECURITIES AND EXCHANGE COMMISSION </P>


</B></FONT><FONT SIZE=2><P ALIGN="CENTER"></P>


</FONT><B><P ALIGN="CENTER">Washington, D.C. 20549 </P>


</B><FONT SIZE=2><P ALIGN="CENTER"></P>


</FONT><B><FONT SIZE=5><P ALIGN="CENTER">FORM 8-K </P>


</B></FONT><FONT SIZE=2><P ALIGN="CENTER"></P>


</FONT><B><P ALIGN="CENTER">CURRENT REPORT </P>


</B><FONT SIZE=2><P ALIGN="CENTER"></P>


</FONT><B><P ALIGN="CENTER">PURSUANT TO SECTION 13 OR 15(d) OF THE </P>


</B><FONT SIZE=2><P ALIGN="CENTER"></P>


</FONT><B><P ALIGN="CENTER">SECURITIES EXCHANGE ACT OF 1934 </P>


</B><FONT SIZE=2><P ALIGN="CENTER"></P>


<B><P ALIGN="CENTER">Date of report (Date of earliest event reported): December 10, 2004 </P>


</B><P ALIGN="CENTER"></P>


</FONT><B><FONT SIZE=6><P ALIGN="CENTER"><A NAME="fis_unidentified_table"></A>Bio-Imaging Technologies, Inc. </P>


</B></FONT><FONT SIZE=2><P ALIGN="CENTER"></P>


</FONT><B><FONT SIZE=1><P ALIGN="CENTER">(Exact Name of Registrant as Specified in Charter) </P>


</B></FONT><FONT SIZE=2><P ALIGN="CENTER"></P>


<P>&nbsp;</P></FONT>


<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 WIDTH=630>


<TR><TD WIDTH="44%" VALIGN="TOP">


<B><FONT SIZE=2><P ALIGN="CENTER">Delaware </B></FONT></TD>


<TD WIDTH="0%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="24%" VALIGN="TOP">


<B><FONT SIZE=2><P ALIGN="CENTER">1-11182 </B></FONT></TD>


<TD WIDTH="0%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="31%" VALIGN="TOP">


<B><FONT SIZE=2><P ALIGN="CENTER">11-2872047 </B></FONT></TD>


<TD WIDTH="0%" VALIGN="TOP">&nbsp;</TD>


</TR>


<TR><TD WIDTH="44%" VALIGN="TOP">


<B><FONT SIZE=1><P ALIGN="CENTER">(State or Other Jurisdiction </P>


</B></FONT><FONT SIZE=2><P ALIGN="CENTER"></P>


</FONT><B><FONT SIZE=1><P ALIGN="CENTER">of Incorporation) </B></FONT></TD>


<TD WIDTH="0%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="24%" VALIGN="TOP">


<B><FONT SIZE=1><P ALIGN="CENTER">(Commission File Number) </B></FONT></TD>


<TD WIDTH="0%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="31%" VALIGN="TOP">


<B><FONT SIZE=1><P ALIGN="CENTER">(IRS Employer </P>


</B></FONT><FONT SIZE=2><P ALIGN="CENTER"></P>


</FONT><B><FONT SIZE=1><P ALIGN="CENTER">Identification No.) </B></FONT></TD>


<TD WIDTH="0%" VALIGN="TOP">&nbsp;</TD>


</TR>


</TABLE>


</CENTER></P>





<FONT SIZE=2></FONT>


<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 WIDTH=390>


<TR><TD WIDTH="83%" VALIGN="TOP">


<B><FONT SIZE=2><P ALIGN="CENTER">826 Newtown-Yardley Road, Newtown, PA </B></FONT></TD>


<TD WIDTH="0%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="16%" VALIGN="TOP">


<B><FONT SIZE=2><P ALIGN="CENTER">18940 </B></FONT></TD>


<TD WIDTH="0%" VALIGN="TOP">&nbsp;</TD>


</TR>


<TR><TD WIDTH="83%" VALIGN="TOP">


<B><FONT SIZE=1><P ALIGN="CENTER">(Address of Principal Executive Offices) </B></FONT></TD>


<TD WIDTH="0%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="16%" VALIGN="TOP">


<B><FONT SIZE=1><P ALIGN="CENTER">(Zip Code) </B></FONT></TD>


<TD WIDTH="0%" VALIGN="TOP">&nbsp;</TD>


</TR>


</TABLE>


</CENTER></P>





<FONT SIZE=2>


<B><P ALIGN="CENTER">(267) 757-3000 </P>


</B><P ALIGN="CENTER"></P>


</FONT><B><FONT SIZE=1><P ALIGN="CENTER">(Registrant's telephone number, including area code) </P>


</B></FONT><FONT SIZE=2><P ALIGN="CENTER"></P>


<B><P ALIGN="CENTER">Not applicable </P>


</B><P ALIGN="CENTER"></P>


</FONT><B><FONT SIZE=1><P ALIGN="CENTER">(Former Name or Former Address, if Changed Since Last Report) </P>


</B></FONT><FONT SIZE=2><P ALIGN="CENTER"></P>


<P>Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P>





<P>Written communications pursuant to Rule 425 under the Section Act (17 CFR 230.425).</P>





<P>Soliciting material pursuant to Rule 14A-12 under the Exchange Act (17 CFR 240.14a-12).</P>





<P>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240-14d-2(b)).</P>





<P>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). </P>





<P>&nbsp;</P>


<P>&nbsp;</P>


<B><P><A NAME="fis_disclosure"></A>ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. </P>


</B>


<P>On December 10, 2004, Bio-Imaging Technologies, Inc. acquired 100% of the stock of Heart Core B.V., a privately held company located in Leiden, the Netherlands.  Heart Core B.V. is a global provider of centralized imaging analysis services in the field of cardiovascular, pulmonary and orthopedic clinical research.  The aggregate purchase price was 1,700,000 Euros which included 175,853 shares of Bio-Imaging Technologies, Inc.'s common stock. </P>





<P>The full text of the press release is attached to this current report on Form 8-K as Exhibit 99.1. </P>





<B><P>Item 9.01. Financial Statements and Exhibits. </P>


</B>


<B><P>(c) Exhibits. </P>


</B>


<B><P><A NAME="fis_unidentified_table_2"></A>Exhibit&nbsp;No.&#9;&#9;Description</P>


</B><P>99.1&#9;&#9;&#9;Press Release of Bio-Imaging Technologies, Inc. dated December 13, 2004.</P>





<P>&nbsp;</P>


<P>&nbsp;</P>


<P>&nbsp;</P>


<P ALIGN="CENTER">&nbsp;</P>


<P ALIGN="CENTER"><A NAME="fis_signatures"></A>SIGNATURE </P>


<P ALIGN="CENTER"></P>


<P>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. </P>





<P>&nbsp;</P>


<P>&#9;&#9;&#9;&#9;&#9;&#9;<B>BIO-IMAGING TECHNOLOGIES, INC.</P>


</B><P>Dated: December 15, 2004&#9;&#9;&#9;&#9;By: /s/ Mark L. Weinstein</P>


<P>&#9;&#9;&#9;&#9;&#9;&#9;Name: Mark L. Weinstein</P>


<P>&#9;&#9;&#9;&#9;&#9;&#9;Title: President and Chief Executive Officer</P>





</FONT><P>&nbsp;</P></BODY>


</HTML>
[{"type": "8-K", "sequence": "1", "filename": "rrd61421.htm", "description": "FORM 8-K", "secsgml_size_bytes": 6064}]
{"company-data": {"conformed-name": "BIO IMAGING TECHNOLOGIES INC", "cik": "0000822418", "assigned-sic": "8071", "irs-number": "112872047", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11182", "film-number": "041204428"}, "business-address": {"street1": "826 NEWTOWN-YARDLEY ROAD", "city": "NEWTOWN", "state": "PA", "zip": "18940-1721", "phone": "2677571360"}, "mail-address": {"street1": "826 NEWTOWN-YARDLEY ROAD", "city": "NEWTOWN", "state": "PA", "zip": "18940-1721"}, "former-company": {"former-conformed-name": "WISE VENTURES INC", "date-changed": "19911023"}}
UNITED STATES
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 10, 2004
Bio-Imaging Technologies, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware
1-11182
11-2872047
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
826 Newtown-Yardley Road, Newtown, PA
18940
(Address of Principal Executive Offices)
(Zip Code)
(267) 757-3000
(Registrant's telephone number, including area code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Section Act (17 CFR 230.425).
Soliciting material pursuant to Rule 14A-12 under the Exchange Act (17 CFR 240.14a-12).
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240-14d-2(b)).
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
On December 10, 2004, Bio-Imaging Technologies, Inc. acquired 100% of the stock of Heart Core B.V., a privately held company located in Leiden, the Netherlands.  Heart Core B.V. is a global provider of centralized imaging analysis services in the field of cardiovascular, pulmonary and orthopedic clinical research.  The aggregate purchase price was 1,700,000 Euros which included 175,853 shares of Bio-Imaging Technologies, Inc.'s common stock.
The full text of the press release is attached to this current report on Form 8-K as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
Exhibit No.		Description
99.1			Press Release of Bio-Imaging Technologies, Inc. dated December 13, 2004.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
BIO-IMAGING TECHNOLOGIES, INC.
Dated: December 15, 2004				By: /s/ Mark L. Weinstein
Name: Mark L. Weinstein
Title: President and Chief Executive Officer